Endocrine Today

The content you need, when you need it.

[HemOnc Today @HemOncToday]

❓ Can #obesity aid #cancer survival?

@kushal_kriplani @Imad24482505 @SUNYDownstate spoke with @GoHealio about the “obesity paradox” — that patients with #GastroIntestinalCancer & obesity on immunotherapy have better outcomes than those with normal BMI. https://t.co/X6XzC1pI3w

[Nephrology News & Issues @Nephronline]

📝 Results of a @GoHealio survey show that more than 70% of health care professionals use AI tools in their practices.

However, more than one-quarter of respondents do not have a formal AI policy in their practices.

Learn more 👇
https://t.co/IY24neuhqh

[Healio @GoHealio]

❗CMS has issued an interim final rule that implements new #workrequirements for adults on #Medicaid. Experts expressed concerns about the new rule, particularly medical frailty exemptions.

🔗Read more, with insight from @DarshaliVyas and @ArthurCaplan: https://t.co/3iPcuvK6Wd

[Nephrology News & Issues @Nephronline]

Gendered differences may impact how medical students rank their preferred schools when matching for #residency, according to study data from @uclaanderson.

Learn more @GoHealio
https://t.co/QKX5RmjZxF

[Cardiology Today @CardiologyToday]

Heart-2 trial🗝️takeaways:
❤️ VERVE-102 safely lowered PCSK9 and LDL in patients with FH or premature CAD
🧬 Genetic base editing may represent a lifelong solution to reducing ASCVD risk in this population
@NEJM #EASCongress2026 @EndocrineToday

https://t.co/n3cKEwrdGU

[Dr. Halis Kaan Akturk @Drhkakturk]

Inhaled insulin is finally FDA approved for children age over 6. That’s a great option for children who miss injections for boluses or wants freedom and privacy. People should need more options for type 1 diabetes @MannKindCorp

[Endocrine Today @EndocrineToday]

📰 Have you seen the BRAND-NEW issue of Endocrine Today?

Featuring a #HealioExclusive on #obesity management beyond #GLP1 therapy, a #NourishtoFlourish on the new Dietary Guidelines for Americans, and more!

@askdrfatima @drard

https://t.co/CjeaKCpT6m

[Endocrine Today @EndocrineToday]

3 green tiles! Are you finishing it? 👀 There’s only one way to find out.

Play today’s WORD DOC and prove it: https://t.co/sstT4YvM5R

#WordGame #DailyPuzzle #HealthcareFun #WORDDOC

[Endocrine Today @EndocrineToday]

♀️ Wegovy induced weight loss and heart-related benefits for women with #obesity, regardless of menopausal status, according to data from two post hoc analyses presented at #ECO2026.

@EASOobesity @dremiliahuvinen @CardiologyToday @GoHealio @healiowomen

https://t.co/Jf7IOuGTYO

[Endocrine Today @EndocrineToday]

🗣️ Hear from Dr. Renee J. Rogers of @KUMedicine as she discusses how to implement lifestyle intervention for adults with #obesity who are receiving medication.

Check out our full #HealioExclusive: https://t.co/VDvwhkPIvq

@drard @askdrfatima @WeillCornell @harvardmed @GoHealio

[Endocrine Today @EndocrineToday]

🗣️ “We can see whether their glucose level at this stage of being asymptomatic persists or whether glucose decompensates in the people who go on to develop #hantavirus infections.”

Read more ⬇️

@SutterHealth @InfectDisNews @DiabetesTechSoc @GoHealio

https://t.co/GNak0QZb9w

[Endocrine Today @EndocrineToday]

🗣️ Read more from @Drhkakturk of @CUAnschutz as he discusses a clinical trial assessing use of ultra-rapid insulin lispro-aabc with MiniMed 780G.

Read the full story on the study ⬇️

@IDinChildren @GoHealio

https://t.co/MHColLxEE3

[Endocrine Today @EndocrineToday]

🫁 Afrezza, an inhaled form of insulin, was originally approved for adults with type 1 or type 2 #diabetes in 2014.

Yesterday, the @US_FDA expanded the approval to children and teens aged 6 years and older.

@MannKindCorp @IDinChildren @GoHealio

https://t.co/hgd9MJ4muH

[Endocrine Today @EndocrineToday]

🦠 Three studies identified in a literature review found associations between worsening #hantavirus severity and elevated glucose levels in humans.

Learn more 👇

@SutterHealth @InfectDisNews @DiabetesTechSoc @GoHealio

https://t.co/suv1L4PeBU

[Endocrine Today @EndocrineToday]

Public health data changes fast. Are you keeping up?

See for yourself and ask Healio AI the following prompt:
“How many confirmed measles cases have there been in the United States in 2026?”

Ask about measles: https://t.co/yaaJ4DZYWi

#HealioAI #PublicHealth #MedicalUpdates

[Endocrine Today @EndocrineToday]

📣 Hear from @Sara_Sleep as she discusses a pilot study that examined the benefits of cognitive behavioral therapy for women experiencing menopause-related insomnia and hot flashes.

Read the full story ⬇️

@BCMDeptMedicine @MenopauseJrnl

https://t.co/9FFsM12xVi

[Endocrine Today @EndocrineToday]

🚨 The @US_FDA has approved Afrezza for children and adolescents with type 1 or type 2 #diabetes, according to an announcement from @MannKindCorp.

Learn more about this new approval ⬇️

@IDinChildren @GoHealio

https://t.co/8iKNWVuSum

[Endocrine Today @EndocrineToday]

💉 Among people with type 1 diabetes using an ultra-rapid-acting insulin and optimal settings on the MiniMed 780G, a glucose management indicator of less than 7% was achieved by

📌 64% of children
📌 90% of adults

@Drhkakturk @CUAnschutz @IDinChildren

https://t.co/uTJbH0rbbe

[Endocrine Today @EndocrineToday]

📰 Check your mail for the new issue of Endocrine Today

Or, visit the link ⬇️ for this month's highlights

https://t.co/SAfTRzyv8F

[Endocrine Today @EndocrineToday]

📱 Could #CGM be used to monitor #glucose among people exposed to hantavirus?

Researchers from @SutterHealth Research Institute explain how this #diabetes technology could be a crucial tool during outbreaks.

@InfectDisNews @DiabetesTechSoc @GoHealio

https://t.co/DRqTdzn8N4